Answers are grounded in this paper and cite their sources.
RA3, in the absence or presence of MET, demonstrated potent therapeutic properties against hyperglycemia-mediated cardiac damage and could be a suitable candidate in the prevention of DCM.
No takes yet. Share an insight, caveat, or question.
Sangweni et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: